OmniAb (OABI) EBT (2021 - 2026)

OmniAb's (OABI) quarterly EBT came in at -$7.3 million in Q1 2026, up 60.31% year-on-year from -$4.5 million in Q1 2025, and up 50.05% on a QoQ basis from -$14.5 million in Q4 2025.

OmniAb (OABI) EBT (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of EBT data on file, last reported at -$7.3 million in Q1 2026.

  • On a quarterly basis, EBT rose 60.31% year-over-year to -$7.3 million in Q1 2026; TTM through Mar 2026 was -$55.3 million, a 18.91% increase from a year earlier, with the FY2025 full-year figure at -$66.3 million, up 7.17% from the prior year.
  • EBT for Q1 2026 stood at -$7.3 million, up from -$14.5 million in the prior quarter.
  • Over the last five years, EBT for OABI reached as high as $9.6 million in Q4 2022 and fell as low as -$21.6 million in Q1 2024.
  • Historically, EBT has averaged -$13.8 million across 5 years, with a median of -$15.5 million in 2024.
  • On a YoY basis, EBT climbed as much as 126.8% in 2022 and fell as far as 575002.97% in 2022.
  • Year by year, EBT stood at $9.6 million in 2022, then sank by 307.82% to -$20.0 million in 2023, then grew by 23.99% to -$15.2 million in 2024, then climbed by 4.45% to -$14.5 million in 2025, then jumped by 50.05% to -$7.3 million in 2026.
  • Per Business Quant data, the three most recent EBT figures were -$7.3 million in Q1 2026, -$14.5 million in Q4 2025, and -$17.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 259.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.49 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 541.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -7.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.27 Mn
Dec 31, 2025 -14.55 Mn
Sep 30, 2025 -17.69 Mn
Jun 30, 2025 -15.76 Mn
Mar 31, 2025 -18.31 Mn
Dec 31, 2024 -15.22 Mn
Sep 30, 2024 -19.08 Mn
Jun 30, 2024 -15.53 Mn
Mar 31, 2024 -21.58 Mn
Dec 31, 2023 -20.03 Mn
Sep 30, 2023 -19.04 Mn
Jun 30, 2023 -18.16 Mn
Mar 31, 2023 -7.13 Mn
Dec 31, 2022 9.64 Mn
Sep 30, 2022 -14.91 Mn
Jun 30, 2022 -12.57 Mn
Mar 31, 2022 -8.22 Mn
Dec 31, 2021 -35.95 Mn
Sep 30, 2021 -170,579.00
Jun 30, 2021 -2,185.00